CohBar, Inc. (CWBR) Q3 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon. My name is Chuck, and I'll be your conference operator today. At this time, I would like to welcome everyone to COBAR's third quarter 2021 financial results conference call. All lines have been placed on mute to eliminate background noise. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad, and to withdraw your question, please press star then two. Please know this event is being recorded. I would now like to turn the conference over to Ms. Jordan Tarazi, Director of Investor Relations at Cobar. Please go ahead. Thank you, Chuck, and thank you, everyone, for joining Cobar's third quarter 2021 financial results conference call. Joining me on today's call is Joe Surrett, Cobar's Chief Executive Officer, Ken Cundy, Cobar's Chief Scientific Officer, and Jeff Buno, Cobar's Chief Financial Officer. COBAR's financial results press release was issued earlier today and may be downloaded from our website at cobar.com. Joe will begin with an introduction, followed by an update on our CB5138-3 program from Ken. Jeff will then provide an overview of the third quarter financial results. We will conclude with Q&A. Before we begin, I'd like to take a moment to remind listeners that the remarks on today's conference call may include forward-looking statements within the meaning of the securities laws. These forward-looking statements include but are not limited to statements regarding the company's business and financial strategies, plans and expectations for its pipeline product candidates, including its lead CB4211 drug candidate program, the therapeutic and commer...